NCT06543043View on ClinicalTrials.gov

A Study to Evaluate the Effects of Phenytoin and Itraconazole on Sonrotoclax (BGB-11417) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 19, 2024

Primary Completion Date

October 8, 2024

Study Completion Date

November 7, 2024

Conditions

Not Determined

Interventions

DRUG

Phenytoin

Administered orally.

DRUG

Itraconazole

Administered orally.

DRUG

sonrotoclax

Administered orally.

Trial Locations (1)

33126

Quotient Sciences, Miami

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Quotient Sciences

INDUSTRY

lead

BeiGene

INDUSTRY